BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10483239)

  • 1. [Apoptosis in the pathogenesis of autoimmune thyroid disease].
    Abe Y
    Nihon Rinsho; 1999 Aug; 57(8):1717-22. PubMed ID: 10483239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
    Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
    Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].
    Bossowski A; Czarnocka B; Stasiak-Barmuta A; Bardadin K; Urban M; Dadan J
    Endokrynol Pol; 2007; 58(4):303-13. PubMed ID: 18058722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytofluorometric analysis of chosen markers of apoptosis CD95/CD95L (Fas/FasL) in thyroid tissues from young patients with Graves' disease and Hashimoto's thyroiditis].
    Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Łyczkowska A; Niedziela M; Bardadin K; Czerwińska J; Dadan J; Baltaziak M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):83-90. PubMed ID: 16813711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
    Shimaoka Y; Hidaka Y; Okumura M; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease.
    Salmaso C; Bagnasco M; Pesce G; Montagna P; Brizzolara R; Altrinetti V; Richiusa P; Galluzzo A; Giordano C
    Ann N Y Acad Sci; 2002 Jun; 966():496-501. PubMed ID: 12114310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death of the autoimmune thyrocyte: is it pushed or does it jump?
    Palazzo FF; Hammond LJ; Goode AW; Mirakian R
    Thyroid; 2000 Jul; 10(7):561-72. PubMed ID: 10958308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoptosis in Hashimoto's thyroiditis].
    Kotani T; Aratake Y; Ohtaki S
    Rinsho Byori; 1997 Nov; 45(11):1038-47. PubMed ID: 9396343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of apoptosis in autoimmune thyroid disorders].
    Bossowski A; Moniuszko A; Bouzyk J; Urban M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):216-20. PubMed ID: 17020659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Fas-mediated apoptosis in thyroid autoimmune disease.
    Borgerson KL; Bretz JD; Baker JR
    Autoimmunity; 1999; 30(4):251-64. PubMed ID: 10524501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
    Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R
    Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoptosis and the thyroid: the Fas pathway].
    Vlaeminck-Guillem V; d'Herbomez-Boidein M; Decoulx M; Wémeau JL
    Presse Med; 2001 Jan; 30(2):74-80. PubMed ID: 11244819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD40 and apoptosis related molecules in autoimmune thyroid diseases.
    Kie JH; Cho MS; Yang WI
    Yonsei Med J; 2001 Oct; 42(5):488-96. PubMed ID: 11675676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
    Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
    Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in autoimmune and non-autoimmune thyroid disease.
    Ludgate M; Jasani B
    J Pathol; 1997 Jun; 182(2):123-4. PubMed ID: 9274519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune thyroid disease: an expanding spectrum.
    Fisher DA; Pandian MR; Carlton E
    Pediatr Clin North Am; 1987 Aug; 34(4):907-18. PubMed ID: 3302899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Fas ligand expression in thyrocytes from patients with Graves' disease.
    Hiromatsu Y; Hoshino T; Yagita H; Koga M; Sakisaka S; Honda J; Yang D; Kayagaki N; Okumura K; Nonaka K
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2896-902. PubMed ID: 10443697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.